Zhang et al. also found that formononetin combined with temozolomide (TMZ) enhanced the expression of Bax, cleaved caspase-3 and cleaved caspase-9, decreased the expression of Bcl-2 and promoted the apoptosis of GBM cells. Here, BCL2 is linked to glioblastoma.